J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

Stock Recap
#PipelineProspector

Xyzal

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

75 API Suppliers, 13 USDMF, 3 CEP/COS, 4 JDMF, 14 EU WC, 21 KDMF, 16 NDC API, 41 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

241 FDF Dossiers, 29 FDA Orange Book, 60 Europe, 42 South Africa, 110 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 2.5MG/5ML, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 1 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 10 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 35 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 17 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 24 Thickeners and Stabilizers, 23 Controlled & Modified Release, 15 Solubilizers, 15 Direct Compression, 14 Co-Processed Excipients, 14 Disintegrants & Superdisintegrants, 14 Granulation, 14 Topical, 13 Film Formers & Plasticizers, 13 Taste Masking, 11 Parenteral, 10 Lubricants & Glidants, 7 Emulsifying Agents, 7 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

24 News #PharmaBuzz

24 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 59 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

44 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

8 Others

8 Others

ANALYTICAL

4 BioAnalytical Methods

4 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/06/2025	Granules India Limited	India	Hiple Co., Ltd.	20090720-40-C-258-15(3)	Levocetirizine hydrochloride	2016-05-02	Granules India Limited	India	Plot No 8, Jawaharlal Nehru Pharma City, Tadi Village, Parawada Mandal, Vitsakhapatnam-531021, Andhra Pradesh, India
28/06/2025	Granules India Limited	India	Dongkwang Pharmaceutical Co., Ltd.	20090720-40-C-258-15(2)	Levocetirizine hydrochloride	2016-02-25	Granules India Limited	India	Plot No 8, Jawaharlal Nehru Pharma City, Tadi Village, Parawada Mandal, Vitsakhapatnam-531021, Andhra Pradesh, INDIA

Xyzal

Xyzal

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

75 API Suppliers

13 USDMF

3 CEP/COS

4 JDMF

14 EU WC

21 KDMF

16 NDC API

41 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

241 FDF Dossiers

29 FDA Orange Book

60 Europe

42 South Africa

110 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 2.5MG/5ML

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

1 SPI Pharma

7 DKSH

1 Pharm-RX Chemical

4 Faran Shimi Pharmaceutical

5 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 ACG Worldwide

10 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

1 Bioplus Life Sciences

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

1 Finar

9 Gangwal Chemicals

4 Ideal Cures

1 Ingredion Pharma Solutions

35 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

1 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

17 Roquette

12 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders

46 Coating Systems & Additives

24 Thickeners and Stabilizers

23 Controlled & Modified Release

15 Solubilizers

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;ORAL - 2.5MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons